We analyzed the STIE of HCC patients treated by immunotherapy and found that patients who did not respond to immunotherapy had higher CD4+ T cells and Th17 cells and lower CD8+ T cells (unpublished data). Here, CD8A is linked to hepatocellular carcinoma.